Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
GALE > SEC Filings for GALE > Form 8-K on 31-May-2013All Recent SEC Filings

Show all filings for GALENA BIOPHARMA, INC. | Request a Trial to NEW EDGAR Online Pro



Entry into a Material Definitive Agreement, Financial Statements and Exhib

Item 1.01 Entry into a Material Definitive Agreement.

Sales Agreements

On May 24, 2013, Galena Biopharma, Inc. ("we," "our" or the "Company") entered into at-the-market sales agreements with each of MLV & Co. LLC ("MLV") and Maxim Group LLC ("Maxim") pursuant to which we may offer and sell from time to time through MLV and Maxim, acting as agents, shares of our common stock, $0.0001 par value per share, having an aggregate offering price of up to $20 million. The offer and sale of our shares through MLV and Maxim will be registered pursuant to our Registration Statement on Form S-3 filed with the Securities and Exchange Commission, or "SEC," on May 24, 2013 and are described in detail in the related preliminary prospectus dated May 24, 2013 included as part of our Registration Statement. No sales will be made until our Registration Statement has been declared effective by the SEC. The offering pursuant to the sales agreements will terminate upon the sale of all shares subject to the sales agreements or the earlier termination of the sales agreements as permitted therein.

Under the sales agreements, MLV and Maxim may sell shares of our common stock by any method permitted by law deemed to be an "at-the-market" offering as defined in Rule 415 of the Securities Act of 1933, as amended, including, but not limited to, sales made directly on The NASDAQ Capital Market, on any other existing trading market for our common stock or to or through a market maker. MLV and Maxim may also sell our shares under the sales agreements by any other method permitted by law, including in privately negotiated transactions. MLV and Maxim have agreed in the sales agreements to use their commercially reasonable efforts consistent with their respective normal trading and sales practices to sell shares in accordance with our instructions (including any price, time or size limit or other customary parameters or conditions we may impose).

We have agreed to pay MLV and Maxim a commission rate of 3.0% of the gross sales price per share of any of our shares of common stock sold through MLV and Maxim, as agents, under the sales agreements. We also have agreed to reimburse MLV and Maxim for legal fees and disbursements, not to exceed $12,500 each, incurred by them in connection with the negotiation and preparation of the sales agreements and have provided MLV and Maxim with customary indemnification rights.

Copies of the sales agreements are incorporated by reference herein as Exhibits 10.1 and 10.2, respectively, and the foregoing summary of the sales agreements is qualified by reference to such exhibits.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

We are filing as part of this report the exhibits listed on the accompanying Index to Exhibits, which information is incorporated herein by reference.

  Add GALE to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for GALE - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.